జర్నల్ ఆఫ్ బ్లడ్ డిజార్డర్స్ & ట్రాన్స్‌ఫ్యూజన్

నైరూప్య

Autologus Stem Cell Transplantation for Cancers: India: 2017

Shreeniwas Shilawant Raut

India is a well-known destination for health tourism including hematopoietic stem cell transplantation for various cancers like multiple myeloma, Hodgkin and non-hodgkin lymphoma. Hematopoietic stem cell transplant is cheaper in India as compared to developed countries and there is a huge cost difference. Here, the numbers of stem cell transplant centres and transplant activity are increasing. In this paper, we summarise present status of autologus stem cell transplant for various cancers in India including the basics of autologus stem cell transplant procedure and reported statistics. This will add to scarcely reported literature in this topic as well as encourage the Indian stem cell transplant activity.